ES2054244T3 - Acondicionamiento para una composicion oftalmologica de maleato de timolol. - Google Patents

Acondicionamiento para una composicion oftalmologica de maleato de timolol.

Info

Publication number
ES2054244T3
ES2054244T3 ES90303231T ES90303231T ES2054244T3 ES 2054244 T3 ES2054244 T3 ES 2054244T3 ES 90303231 T ES90303231 T ES 90303231T ES 90303231 T ES90303231 T ES 90303231T ES 2054244 T3 ES2054244 T3 ES 2054244T3
Authority
ES
Spain
Prior art keywords
timolol maleate
conditioning
ophthalmological composition
contain sodium
dissolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90303231T
Other languages
English (en)
Inventor
Montague Cecil Solomon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chatfield Pharmaceuticals Ltd
Original Assignee
Chatfield Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10644065&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2054244(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chatfield Pharmaceuticals Ltd filed Critical Chatfield Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2054244T3 publication Critical patent/ES2054244T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

UNA PREPARACION OFTALMICA EN FORMA DE DOSIS UNICA COMPRENDE UNA DISOLUCION ACUOSA DE MALEATO DE TIMOLOL EN LA AUSENCIA DE NINGUN AGENTE TAMPONADOR O PRESERVATIVO. PUEDE CONTENER CLORURO DE SODIO PARA AUMENTAR LA TONACIDAD DE LA DISOLUCION O HACERLA ISOTOMICA, Y PUEDE CONTENER MAS ADELANTE HIDROXIDO DE SODIO PARA AJUSTAR EL PH EL NIVEL DE 6.5 A 7.5. LA PREPARACION SE SUMINISTRA PREFERIBLEMENTE EN CONTENEDORES DE PLASTICO FORMADOS MEDIANTE EL PROCESO DE SOPLADO-LLENADO-SELLADO, CONTENIENDO CADA RECIPIENTE DE 0.1 A 0.3 ML DE SOLUCION Y DE 0.001 A 5.0 MG DE MALEATO DE TIMOLOL.
ES90303231T 1988-09-22 1990-03-27 Acondicionamiento para una composicion oftalmologica de maleato de timolol. Expired - Lifetime ES2054244T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888822285A GB8822285D0 (en) 1988-09-22 1988-09-22 Opthalmic preparations

Publications (1)

Publication Number Publication Date
ES2054244T3 true ES2054244T3 (es) 1994-08-01

Family

ID=10644065

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90303231T Expired - Lifetime ES2054244T3 (es) 1988-09-22 1990-03-27 Acondicionamiento para una composicion oftalmologica de maleato de timolol.

Country Status (3)

Country Link
EP (1) EP0448856B1 (es)
ES (1) ES2054244T3 (es)
GB (2) GB8822285D0 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations
GB9013543D0 (en) * 1990-06-18 1990-08-08 Beecham Group Plc Novel products
DK0577913T3 (da) * 1992-07-08 1998-01-26 Santen Oy Ophthalmisk præparat indeholdende timolol-hemihydrat
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB832056A (en) * 1958-08-28 1960-04-06 Harry William Hind Improved dispenser for dispensing of ophthalmic medicaments
GB1256502A (es) * 1968-02-26 1971-12-08
ZA734927B (en) * 1973-07-19 1974-11-27 Remedia Ltd Improvements in and relating to the packaging of liquids in dosage form
NZ182022A (en) * 1975-09-26 1978-12-18 Merck & Co Inc Antiglaucoma compositions comprising 1-t butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)-2-prodanol hydogen maleate
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
GB8822285D0 (en) * 1988-09-22 1988-10-26 Ddsa Pharmaceuticals Ltd Opthalmic preparations

Also Published As

Publication number Publication date
GB2225237B (en) 1992-03-25
EP0448856A1 (en) 1991-10-02
GB8822285D0 (en) 1988-10-26
GB2225237A (en) 1990-05-30
EP0448856B1 (en) 1993-02-03
GB8921506D0 (en) 1989-11-08

Similar Documents

Publication Publication Date Title
US4931441A (en) Stabilized aqueous leucovorin calcium compositions
DK170500B1 (da) Farmaceutisk præparat, der undergår væske-gel faseovergang
US5460834A (en) Combinations of polymers for use in physiological tear compositions
US4425345A (en) Pharmaceutical composition containing triamterene
KR900015737A (ko) 배합물
IL92351A0 (en) Stabilized aqueous ophthalmic solutions
ES2064634T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
ES2127375T3 (es) Procedimiento de administracion de un farmaco oftalmico.
EP1124535B1 (en) Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
EP1324782B1 (en) Stabilized ophthalmic hydrogen peroxide solutions
RU97106214A (ru) Глазные капли "пиротоник"
CA2282757A1 (en) Opthalmic composition
ES2054244T3 (es) Acondicionamiento para una composicion oftalmologica de maleato de timolol.
KR100307846B1 (ko) 생리학적눈물조성물에사용되는중합체조성물
US5200180A (en) Pharmaceutical composition for the treatment of the human eye
ES2115047T3 (es) Agente de consolidacion de los huesos; y alimento y bebida que contiene el indicado agente.
ITRM20010438A1 (it) Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
SI0875248T1 (en) Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
GB2169508A (en) Ophthalmic solutions containing hydroxyethyl cellulose
KR880001290A (ko) β-차단제 및 필로카르핀-함유 제제
US3415929A (en) Ophthalmic solution containing poly-1,3-beta-glucoside
ES2067206T3 (es) Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria.
EP2343048A2 (en) Stabilized and preserved ketotifen ophthalmic compositions
EP0362277A1 (en) Preservative free ophthalmic ointments
FR2661091B1 (fr) Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 448856

Country of ref document: ES